EUR J GASTROEN HEPAT 润色咨询

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

出版年份:1989 年文章数:3733 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:5.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肝病方向<br>经验分享:6月29投稿的,8月11让修改,提了一条主要意见,感觉编辑措辞还是很温和的,然后我9月15再次提交,21号就接收了,还是蛮快的,我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号?已经7天了,还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了,是应该主动要求退回还是等编辑退呢?目前状态是已分配稿号(上传3天后)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:临床肝病方向,投稿6次,秒拒3次,3次外审,不到一个月修回,而后顺利接收。总体上,难度不大,但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的,而且貌似愿意选择推荐的审稿人,哪怕推荐的是中国人。一般两个审稿人,有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向:肝病方向<br>经验分享:投稿两周多,直接录用,临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好,请问copyright那个表格在哪里下载?能不能发我一份?需要全部签字上传么,谢谢。<span class="quote">leook555 2019-08-26 16:49:00 发表:<br>original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。</span>, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189587, encodeId=c8ae118958e30, content=请问投稿后多久分配稿号?<br>提交了大概5天了,所有作者也都确认了,但是一直没有分配稿号,各位老师知道是什么原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Tue Feb 01 20:44:00 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091221, encodeId=40d220912210a, content=想问下接收后多久发proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Fri Sep 30 18:11:09 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241471, encodeId=c00d12414e139, content=偏重的研究方向:biomarker;肝癌<br>经验分享:插眼, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:36:54 CST 2022, time=2022-08-28, status=1, ipAttribution=)]
    2023-09-22 ms6000001416279458 来自湖北省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:肝病方向
    经验分享:6月29投稿的,8月11让修改,提了一条主要意见,感觉编辑措辞还是很温和的,然后我9月15再次提交,21号就接收了,还是蛮快的,我另一篇文章三个多月了还在一审

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肝病方向<br>经验分享:6月29投稿的,8月11让修改,提了一条主要意见,感觉编辑措辞还是很温和的,然后我9月15再次提交,21号就接收了,还是蛮快的,我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号?已经7天了,还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了,是应该主动要求退回还是等编辑退呢?目前状态是已分配稿号(上传3天后)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:临床肝病方向,投稿6次,秒拒3次,3次外审,不到一个月修回,而后顺利接收。总体上,难度不大,但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的,而且貌似愿意选择推荐的审稿人,哪怕推荐的是中国人。一般两个审稿人,有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向:肝病方向<br>经验分享:投稿两周多,直接录用,临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好,请问copyright那个表格在哪里下载?能不能发我一份?需要全部签字上传么,谢谢。<span class="quote">leook555 2019-08-26 16:49:00 发表:<br>original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。</span>, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189587, encodeId=c8ae118958e30, content=请问投稿后多久分配稿号?<br>提交了大概5天了,所有作者也都确认了,但是一直没有分配稿号,各位老师知道是什么原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Tue Feb 01 20:44:00 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091221, encodeId=40d220912210a, content=想问下接收后多久发proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Fri Sep 30 18:11:09 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241471, encodeId=c00d12414e139, content=偏重的研究方向:biomarker;肝癌<br>经验分享:插眼, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:36:54 CST 2022, time=2022-08-28, status=1, ipAttribution=)]
    2023-08-15 ms1000001347062777 来自北京

    请问submit后多久分配稿号?已经7天了,还是submitted to journal

    5

    展开5条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肝病方向<br>经验分享:6月29投稿的,8月11让修改,提了一条主要意见,感觉编辑措辞还是很温和的,然后我9月15再次提交,21号就接收了,还是蛮快的,我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号?已经7天了,还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了,是应该主动要求退回还是等编辑退呢?目前状态是已分配稿号(上传3天后)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:临床肝病方向,投稿6次,秒拒3次,3次外审,不到一个月修回,而后顺利接收。总体上,难度不大,但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的,而且貌似愿意选择推荐的审稿人,哪怕推荐的是中国人。一般两个审稿人,有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向:肝病方向<br>经验分享:投稿两周多,直接录用,临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好,请问copyright那个表格在哪里下载?能不能发我一份?需要全部签字上传么,谢谢。<span class="quote">leook555 2019-08-26 16:49:00 发表:<br>original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。</span>, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189587, encodeId=c8ae118958e30, content=请问投稿后多久分配稿号?<br>提交了大概5天了,所有作者也都确认了,但是一直没有分配稿号,各位老师知道是什么原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Tue Feb 01 20:44:00 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091221, encodeId=40d220912210a, content=想问下接收后多久发proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Fri Sep 30 18:11:09 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241471, encodeId=c00d12414e139, content=偏重的研究方向:biomarker;肝癌<br>经验分享:插眼, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:36:54 CST 2022, time=2022-08-28, status=1, ipAttribution=)]
    2023-08-08 ms4000001065776869 来自北京

    想问问大家现在under review大概多久会给消息?

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肝病方向<br>经验分享:6月29投稿的,8月11让修改,提了一条主要意见,感觉编辑措辞还是很温和的,然后我9月15再次提交,21号就接收了,还是蛮快的,我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号?已经7天了,还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了,是应该主动要求退回还是等编辑退呢?目前状态是已分配稿号(上传3天后)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:临床肝病方向,投稿6次,秒拒3次,3次外审,不到一个月修回,而后顺利接收。总体上,难度不大,但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的,而且貌似愿意选择推荐的审稿人,哪怕推荐的是中国人。一般两个审稿人,有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向:肝病方向<br>经验分享:投稿两周多,直接录用,临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好,请问copyright那个表格在哪里下载?能不能发我一份?需要全部签字上传么,谢谢。<span class="quote">leook555 2019-08-26 16:49:00 发表:<br>original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。</span>, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189587, encodeId=c8ae118958e30, content=请问投稿后多久分配稿号?<br>提交了大概5天了,所有作者也都确认了,但是一直没有分配稿号,各位老师知道是什么原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Tue Feb 01 20:44:00 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091221, encodeId=40d220912210a, content=想问下接收后多久发proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Fri Sep 30 18:11:09 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241471, encodeId=c00d12414e139, content=偏重的研究方向:biomarker;肝癌<br>经验分享:插眼, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:36:54 CST 2022, time=2022-08-28, status=1, ipAttribution=)]
    2023-03-31 1473ac4am82暂无昵称 来自四川省

    作者之一在邮箱确认和勾选声明的时候有一个勾错了,是应该主动要求退回还是等编辑退呢?目前状态是已分配稿号(上传3天后)。

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肝病方向<br>经验分享:6月29投稿的,8月11让修改,提了一条主要意见,感觉编辑措辞还是很温和的,然后我9月15再次提交,21号就接收了,还是蛮快的,我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号?已经7天了,还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了,是应该主动要求退回还是等编辑退呢?目前状态是已分配稿号(上传3天后)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:临床肝病方向,投稿6次,秒拒3次,3次外审,不到一个月修回,而后顺利接收。总体上,难度不大,但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的,而且貌似愿意选择推荐的审稿人,哪怕推荐的是中国人。一般两个审稿人,有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向:肝病方向<br>经验分享:投稿两周多,直接录用,临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好,请问copyright那个表格在哪里下载?能不能发我一份?需要全部签字上传么,谢谢。<span class="quote">leook555 2019-08-26 16:49:00 发表:<br>original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。</span>, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189587, encodeId=c8ae118958e30, content=请问投稿后多久分配稿号?<br>提交了大概5天了,所有作者也都确认了,但是一直没有分配稿号,各位老师知道是什么原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Tue Feb 01 20:44:00 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091221, encodeId=40d220912210a, content=想问下接收后多久发proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Fri Sep 30 18:11:09 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241471, encodeId=c00d12414e139, content=偏重的研究方向:biomarker;肝癌<br>经验分享:插眼, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:36:54 CST 2022, time=2022-08-28, status=1, ipAttribution=)]
    2018-12-09 fzdndx

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:临床肝病方向,投稿6次,秒拒3次,3次外审,不到一个月修回,而后顺利接收。总体上,难度不大,但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的,而且貌似愿意选择推荐的审稿人,哪怕推荐的是中国人。一般两个审稿人,有一次只有一个。

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肝病方向<br>经验分享:6月29投稿的,8月11让修改,提了一条主要意见,感觉编辑措辞还是很温和的,然后我9月15再次提交,21号就接收了,还是蛮快的,我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号?已经7天了,还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了,是应该主动要求退回还是等编辑退呢?目前状态是已分配稿号(上传3天后)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:临床肝病方向,投稿6次,秒拒3次,3次外审,不到一个月修回,而后顺利接收。总体上,难度不大,但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的,而且貌似愿意选择推荐的审稿人,哪怕推荐的是中国人。一般两个审稿人,有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向:肝病方向<br>经验分享:投稿两周多,直接录用,临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好,请问copyright那个表格在哪里下载?能不能发我一份?需要全部签字上传么,谢谢。<span class="quote">leook555 2019-08-26 16:49:00 发表:<br>original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。</span>, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189587, encodeId=c8ae118958e30, content=请问投稿后多久分配稿号?<br>提交了大概5天了,所有作者也都确认了,但是一直没有分配稿号,各位老师知道是什么原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Tue Feb 01 20:44:00 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091221, encodeId=40d220912210a, content=想问下接收后多久发proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Fri Sep 30 18:11:09 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241471, encodeId=c00d12414e139, content=偏重的研究方向:biomarker;肝癌<br>经验分享:插眼, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:36:54 CST 2022, time=2022-08-28, status=1, ipAttribution=)]
    2022-07-30 099092753

    偏重的研究方向:肝病方向
    经验分享:投稿两周多,直接录用,临床脂肪肝横断面研究文章

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肝病方向<br>经验分享:6月29投稿的,8月11让修改,提了一条主要意见,感觉编辑措辞还是很温和的,然后我9月15再次提交,21号就接收了,还是蛮快的,我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号?已经7天了,还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了,是应该主动要求退回还是等编辑退呢?目前状态是已分配稿号(上传3天后)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:临床肝病方向,投稿6次,秒拒3次,3次外审,不到一个月修回,而后顺利接收。总体上,难度不大,但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的,而且貌似愿意选择推荐的审稿人,哪怕推荐的是中国人。一般两个审稿人,有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向:肝病方向<br>经验分享:投稿两周多,直接录用,临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好,请问copyright那个表格在哪里下载?能不能发我一份?需要全部签字上传么,谢谢。<span class="quote">leook555 2019-08-26 16:49:00 发表:<br>original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。</span>, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189587, encodeId=c8ae118958e30, content=请问投稿后多久分配稿号?<br>提交了大概5天了,所有作者也都确认了,但是一直没有分配稿号,各位老师知道是什么原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Tue Feb 01 20:44:00 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091221, encodeId=40d220912210a, content=想问下接收后多久发proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Fri Sep 30 18:11:09 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241471, encodeId=c00d12414e139, content=偏重的研究方向:biomarker;肝癌<br>经验分享:插眼, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:36:54 CST 2022, time=2022-08-28, status=1, ipAttribution=)]
    2019-12-06 147a1e7dm81(暂无昵称)

    您好,请问copyright那个表格在哪里下载?能不能发我一份?需要全部签字上传么,谢谢。leook555 2019-08-26 16:49:00 发表:
    original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。

    leook555 2019-08-26 16:49:00 发表: original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肝病方向<br>经验分享:6月29投稿的,8月11让修改,提了一条主要意见,感觉编辑措辞还是很温和的,然后我9月15再次提交,21号就接收了,还是蛮快的,我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号?已经7天了,还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了,是应该主动要求退回还是等编辑退呢?目前状态是已分配稿号(上传3天后)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:临床肝病方向,投稿6次,秒拒3次,3次外审,不到一个月修回,而后顺利接收。总体上,难度不大,但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的,而且貌似愿意选择推荐的审稿人,哪怕推荐的是中国人。一般两个审稿人,有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向:肝病方向<br>经验分享:投稿两周多,直接录用,临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好,请问copyright那个表格在哪里下载?能不能发我一份?需要全部签字上传么,谢谢。<span class="quote">leook555 2019-08-26 16:49:00 发表:<br>original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。</span>, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189587, encodeId=c8ae118958e30, content=请问投稿后多久分配稿号?<br>提交了大概5天了,所有作者也都确认了,但是一直没有分配稿号,各位老师知道是什么原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Tue Feb 01 20:44:00 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091221, encodeId=40d220912210a, content=想问下接收后多久发proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Fri Sep 30 18:11:09 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241471, encodeId=c00d12414e139, content=偏重的研究方向:biomarker;肝癌<br>经验分享:插眼, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:36:54 CST 2022, time=2022-08-28, status=1, ipAttribution=)]
    2022-02-01 白.

    请问投稿后多久分配稿号?
    提交了大概5天了,所有作者也都确认了,但是一直没有分配稿号,各位老师知道是什么原因吗

    8

    展开8条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肝病方向<br>经验分享:6月29投稿的,8月11让修改,提了一条主要意见,感觉编辑措辞还是很温和的,然后我9月15再次提交,21号就接收了,还是蛮快的,我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号?已经7天了,还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了,是应该主动要求退回还是等编辑退呢?目前状态是已分配稿号(上传3天后)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:临床肝病方向,投稿6次,秒拒3次,3次外审,不到一个月修回,而后顺利接收。总体上,难度不大,但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的,而且貌似愿意选择推荐的审稿人,哪怕推荐的是中国人。一般两个审稿人,有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向:肝病方向<br>经验分享:投稿两周多,直接录用,临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好,请问copyright那个表格在哪里下载?能不能发我一份?需要全部签字上传么,谢谢。<span class="quote">leook555 2019-08-26 16:49:00 发表:<br>original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。</span>, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189587, encodeId=c8ae118958e30, content=请问投稿后多久分配稿号?<br>提交了大概5天了,所有作者也都确认了,但是一直没有分配稿号,各位老师知道是什么原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Tue Feb 01 20:44:00 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091221, encodeId=40d220912210a, content=想问下接收后多久发proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Fri Sep 30 18:11:09 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241471, encodeId=c00d12414e139, content=偏重的研究方向:biomarker;肝癌<br>经验分享:插眼, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:36:54 CST 2022, time=2022-08-28, status=1, ipAttribution=)]
    2022-09-30 ms5000001116886064

    想问下接收后多久发proof

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肝病方向<br>经验分享:6月29投稿的,8月11让修改,提了一条主要意见,感觉编辑措辞还是很温和的,然后我9月15再次提交,21号就接收了,还是蛮快的,我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号?已经7天了,还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了,是应该主动要求退回还是等编辑退呢?目前状态是已分配稿号(上传3天后)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:临床肝病方向,投稿6次,秒拒3次,3次外审,不到一个月修回,而后顺利接收。总体上,难度不大,但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的,而且貌似愿意选择推荐的审稿人,哪怕推荐的是中国人。一般两个审稿人,有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向:肝病方向<br>经验分享:投稿两周多,直接录用,临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好,请问copyright那个表格在哪里下载?能不能发我一份?需要全部签字上传么,谢谢。<span class="quote">leook555 2019-08-26 16:49:00 发表:<br>original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。</span>, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向,5月底投稿,第二天状态变成Under review,然后状态一直持续了2个月,中间写信催稿,主编说在审稿中,让再等等。8月17号突然收到拒稿,理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189587, encodeId=c8ae118958e30, content=请问投稿后多久分配稿号?<br>提交了大概5天了,所有作者也都确认了,但是一直没有分配稿号,各位老师知道是什么原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Tue Feb 01 20:44:00 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091221, encodeId=40d220912210a, content=想问下接收后多久发proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Fri Sep 30 18:11:09 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241471, encodeId=c00d12414e139, content=偏重的研究方向:biomarker;肝癌<br>经验分享:插眼, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:36:54 CST 2022, time=2022-08-28, status=1, ipAttribution=)]
    2022-08-28 Doctor小雷

    偏重的研究方向:biomarker;肝癌
    经验分享:插眼

    2

    展开2条回复
共109条页码: 1/11页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分